Press Release: Ligand Announces That Janssen Has Received Approval From European Commission for TECVAYLI(R) (Teclistamab) for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Press Release: Ligand Announces That Janssen Has Received Approval From European Commission for TECVAYLI(R) (Teclistamab) for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
新聞稿：Ligand公司宣佈，Janssen已經獲得歐洲委員會TECVAYLI(R)(Teclistamab)的批准，用於治療複發性或難治性多發性骨髓瘤患者
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。